LARA CAMPAGNA: Open Payments
NPI 1487703492 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 84 payments from 20 companies in 2025. Trend: 2023 $1,437 · 2024 $1,732 · 2025 $1,882
Food & beverage: $1,791Education: $91
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $399 |
| GlaxoSmithKline, LLC. | 17 | $253 |
| Grifols USA, LLC | 4 | $190 |
| Insmed, Inc. | 9 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $110 |
| GENZYME CORPORATION | 4 | $103 |
| Merck Sharp & Dohme LLC | 4 | $101 |
| Amgen Inc. | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 4 | $61 |
Products named: DUPIXENT, NUCALA, Prolastin-C Liquid, Arikayce, AIRSUPRA, JASCAYD, FASENRA, TEZSPIRE.
Industry payments across NC — which companies pay providers there.
